Feed OGI
OG

OrganiGram Holdings Inc. OGI NASDAQ · Healthcare · Canada

$0.72 -12.62% -$0.10

Summary

56 / 100 · Bulios Score

What speaks for it

  • Out of every 100 CAD of revenue, 28 CAD is left as net profit.
  • The share price is below the Bulios Fair Price.

What to watch

  • It missed profit estimates 6 times in the last 8 quarters.
  • It reports a profit, yet spends more cash than it brings in.
  • Revenue growth is slowing: 8.5% a year over the last 3 years against 16% over 5 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $0.72

By our assumptions the business is worth more than its shares cost today.

P/E today 1.9
Drug Manufacturers - Specialty & Generic industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 1.9 CAD for 1 CAD of yearly profit.

Valuation in detail

Is it growing?

Slowly

Revenue (CAD)

Diluted EPS (CAD)

  • Analyst estimate

Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 8.5% a year.

Growth in detail

Does it make money?

Reasonably

Where 100 CAD of revenue goes

Net profit, industry median (Drug Manufacturers - Specialty & Generic) 9.9 CAD

Out of every 100 CAD of revenue, 28 CAD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

40% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

International Business To Business brings in 69% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy